BioIQ Announces the Addition of 26 New Health Plan Customers in 2021

by growthiqpartners_rehbah | Jan 6, 2022

BioIQ’s population health testing platform enables a growing number of health plans to close care gaps, reduce medical costs, and improve member outcomes. ATLANTA, Jan. 6, 2022 — BioIQ, an industry leading digital population health and testing platform company...

BioIQ Ranked One of the Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™

by growthiqpartners_rehbah | Dec 1, 2021

Attributes record revenue growth to rising demand for reliable access to convenient health screening solutions at scale. ATLANTA – Dec. 1, 2021 –  BioIQ, an analytics-driven population health and testing platform company for top employers, health plans, and government...

BioIQ Approaches Milestone of One Million COVID-19 Tests and Record Health Testing in the Home as Delta Variant Cases Climb

by growthiqpartners_rehbah | Aug 11, 2021

Demand for at-home COVID-19 and routine health screening test kits has skyrocketed as employers and consumers seek more convenient ways to access care during the pandemic and beyond.   ATLANTA, August 11, 2021 – BioIQ, an industry leading digital population health and...

BioIQ Announced as 2021 Georgia Fast 40 Program Honoree by ACG Atlanta

by growthiqpartners_rehbah | May 26, 2021

The program recognizes exceptional revenue and employee growth among Georgia-based middle market companies. ATLANTA, May 26, 2021 – BioIQ, an analytics-driven population health and testing platform company for top employers, health plans, and government agencies, was...

7 of 10 Fully Insured Americans Represented by BioIQ in 2020

by growthiqpartners_rehbah | Jan 27, 2021

BioIQ’s population health testing platform was a key solution in the pandemic for millions of Americans, including those with social determinants of health. ATLANTA – JANUARY 27, 2021 – In 2020, BioIQ’s clients represented 7 out of 10 fully insured Americans. With...